Indication
Aspergillosis
Aspergillosis is a spectrum of fungal diseases caused by ubiquitous environmental molds of the genus *Aspergillus*, most frequently *Aspergillus fumigatus*. Read more about Aspergillosis
63 drugs 45 manufacturers
Drugs that treat it
Common Aspergillosis therapies.
VORICONAZOLE
VORICONAZOLE
VORICONAZOLE
VORICONAZOLE
ITRACONAZOLE
VFEND IV (voriconazole)
ONMEL (itraconazole)
VORICONAZOLE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAspergillosis is a spectrum of fungal diseases caused by ubiquitous environmental molds of the genus *Aspergillus*, most frequently *Aspergillus fumigatus*.
It primarily affects the respiratory system—including the lungs and paranasal sinuses—predisposing individuals with underlying pulmonary conditions or impaired host immunity.
The clinical and pathophysiologic manifestations depend on immune status, ranging from hypersensitivity reactions such as allergic bronchopulmonary aspergillosis in patients with asthma or cystic fibrosis, to noninvasive fungus balls (aspergillomas) in pre-existing pulmonary cavities, and angioinvasive, life-threatening tissue destruction with potential hematogenous dissemination in severely immunocompromised hosts.
- cdc.gov
Aspergillosis is a spectrum of fungal diseases caused by ubiquitous environmental molds of the genus *Aspergillus*, most frequently *Aspergillus fumigatus* It primarily affects the respiratory system—including the lungs and paranasal sinuses—predisposing individuals with underlying pulmonary conditions or impaired host immunity The clinical and pathophysiologic manifestations depend on immune status, ranging from hypersensitivity reactions such as allergic bronchopulmonary aspergillosis in patie...
- nih.gov
Aspergillosis is a spectrum of fungal diseases caused by ubiquitous environmental molds of the genus *Aspergillus*, most frequently *Aspergillus fumigatus* It primarily affects the respiratory system—including the lungs and paranasal sinuses—predisposing individuals with underlying pulmonary conditions or impaired host immunity The clinical and pathophysiologic manifestations depend on immune status, ranging from hypersensitivity reactions such as allergic bronchopulmonary aspergillosis in patie...
- nih.gov
The clinical and pathophysiologic manifestations depend on immune status, ranging from hypersensitivity reactions such as allergic bronchopulmonary aspergillosis in patients with asthma or cystic fibrosis, to noninvasive fungus balls (aspergillomas) in pre-existing pulmonary cavities, and angioinvasive, life-threatening tissue destruction with potential hematogenous dissemination in severely immunocompromised hosts
Personalize your experience
Follow Aspergillosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.